Prellis Biologics

prellisbio.com

Prellis Biologics is pioneering the integration of human biology with machine learning to revolutionize antibody discovery. Their EXIS™ platform utilizes bioprinted lymph node organoids to replicate the human immune system, enabling the rapid identification of fully human antibodies with low immunogenicity risk. By leveraging advanced AI and laser bioprinting technology, Prellis aims to accelerate the development of next-generation therapeutics, making significant strides in drug discovery and therapeutic innovation. Their unique approach combines natural immune processes with cutting-edge technology, positioning them as leaders in the biotech space with strategic partnerships to enhance therapeutic development.